Mark J Hobeika
Overview
Explore the profile of Mark J Hobeika including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
136
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yun A, Rogers A, Krisl J, Kagan A, Adrogue H, Khan A, et al.
Transplant Direct
. 2025 Mar;
11(3):e1769.
PMID: 40034162
Background: Focal segmental glomerulosclerosis (FSGS) recurs after kidney transplantation (KT) in 30%-50% of recipients. Recurrence is associated with early graft loss in up to 60% of cases. This study aimed...
2.
Semaan S, Connor A, Saharia A, Kodali S, Elaileh A, Patel K, et al.
Transplant Proc
. 2025 Feb;
57(2):255-263.
PMID: 39939239
Background: Cholangiocarcinoma (CCA) has rising incidence and mortality rates. Outcomes from combination systemic, loco-regional therapy (LRT) and liver transplantation (LT) are improving, but more granular data are needed to inform...
3.
Soliman N, Connor A, Saharia A, Kodali S, Elaileh A, Patel K, et al.
Transplant Direct
. 2025 Feb;
11(3):e1760.
PMID: 39936132
Background: Perihilar cholangiocarcinoma (phCCA) has excellent outcomes following liver transplantation (LT). Neoadjuvant radiation-based locoregional therapy is standard-of-care. Gemcitabine and cisplatin (gem/cis) combination systemic therapies have improved outcomes in advanced settings,...
4.
Hassanain H, Connor A, Brombosz E, Patel K, Elaileh A, Basra T, et al.
Transplant Direct
. 2025 Jan;
11(2):e1746.
PMID: 39866680
Background: Hepatocellular carcinoma (HCC) has a rising incidence and mortality in North America. Liver transplantation (LT) with adjunctive therapies offers excellent outcomes. However, HCC recurrences are associated with high mortality....
5.
Brombosz E, Hobeika M, Kodali S, Connor A, Saharia A, Mobley C, et al.
Transplant Proc
. 2024 Dec;
56(10):2203-2212.
PMID: 39617682
Background: The deceased donor shortage in the United States has led to increased utilization extended criteria donor (ECD) liver grafts. Centers often utilize ECD grafts in patients with low Model...
6.
Brombosz E, Moore L, Mobley C, Kodali S, Saharia A, Hobeika M, et al.
Front Transplant
. 2024 Jul;
2:1181770.
PMID: 38993927
Background: Liver retransplantation (reLT) has historically had inferior survival relative to primary liver transplant (LT). To improve outcomes after reLT, researchers have identified factors predicting overall (OS) and/or graft survival...
7.
Hobeika M, Roll G
Am J Transplant
. 2024 Jun;
24(10):1722-1723.
PMID: 38897353
No abstract available.
8.
Brubaker A, Sellers M, Abt P, Croome K, Merani S, Wall A, et al.
JAMA Surg
. 2024 Apr;
159(6):677-685.
PMID: 38568597
Importance: Normothermic regional perfusion (NRP) is an emerging recovery modality for transplantable allografts from controlled donation after circulatory death (cDCD) donors. In the US, only 11.4% of liver recipients who...
9.
Kodali S, Mobley C, Brombosz E, Lopez A, Graves R, Ontiveros J, et al.
Transpl Immunol
. 2024 Mar;
84:102034.
PMID: 38499048
Background: Although Hispanic patients have high rates of end-stage liver disease and liver cancer, for which liver transplantation (LT) offers the best long-term outcomes, they are less likely to receive...
10.
Connor A, Adelman M, Mobley C, Moaddab M, Erhardt A, Hsu D, et al.
Transplant Direct
. 2024 Mar;
10(4):e1590.
PMID: 38464428
Background: The COVID-19 pandemic has led to an increase in SARS-CoV-2-test positive potential organ donors. The benefits of life-saving liver transplantation (LT) must be balanced against the potential risk of...